Imagine if, in a year’s time, 300m doses of a safe and effective Covid-19 vaccine have been manufactured in Donald Trump’s America, Xi Jinping’s China or Boris Johnson’s Britain. Who is going to get them? What are the chances that a nurse in India, or a doctor in Brazil, let alone a bus driver in Nigeria or a diabetic in Tanzania, will be given priority? The answer must be virtually nil.
想象一下，如果在一年内，唐纳德•特朗普(Donald Trump)领导的美国、习近平领导的manbetx3.0 或鲍里斯•约翰逊(Boris Johnson)领导的英国生产出了3亿剂安全有效的新型冠状病毒肺炎（COVID-19，即2019冠状病毒病）疫苗，谁会得到它们？印度的护士、巴西的医生，更不用说尼日利亚的公交车司机或坦桑尼亚的糖尿病患者，这些人能优先接种疫苗的可能性有多大？答案一定几乎为零。
您已阅读9%（581字），剩余91%（5936字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。